Filter Results :

Your search for Neural returned 33 reports

Sort by


Neuralstem, Inc. (CUR) - Financial and Strategic SWOT Analysis Review

07 Jun 2015  |  Published by:  GlobalData
SummaryNeuralstem, Inc. (Neuralstem) is a pharmaceutical company. The company develops and markets medicines based on human neural stem cell technology and cell therapy. It provides cell therapy treatment for ALS, ischemic stroke, spinal cord injury, glioblastoma, multiple sclerosis, optic neuritis,...

$ 300.00

Read More

Neuralstem, Inc. (CUR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

28 May 2015  |  Published by:  GlobalData
SummaryNeuralstem, Inc. (Neuralstem) is a pharmaceutical company. The company develops and markets medicines based on human neural stem cell technology and cell therapy. It provides cell therapy treatment for ALS, ischemic stroke, spinal cord injury, glioblastoma, multiple sclerosis, optic neuritis,...

$ 250.00

Read More

Postherpetic Neuralgia - Pipeline Review, H1 2015

30 Apr 2015  |  Published by:  Global Markets Direct
SummaryGlobal Markets Direct’s, ‘Postherpetic Neuralgia - Pipeline Review, H1 2015’, provides an overview of the Postherpetic Neuralgia’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Postherpetic Neuralgia, complete with comparative analysis ...

$ 2,000.00

Read More

Neuralstem, Inc. (CUR) - Medical Equipment - Deals and Alliances Profile

10 Apr 2015  |  Published by:  GlobalData
SummaryNeuralstem, Inc. (Neuralstem) is a pharmaceutical company. The company develops and markets medicines based on human neural stem cell technology and cell therapy. It provides cell therapy treatment for ALS, ischemic stroke, spinal cord injury, glioblastoma, multiple sclerosis, optic neuritis,...

$ 250.00

Read More

Neuraltus Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

10 Apr 2015  |  Published by:  GlobalData
SummaryNeuraltus Pharmaceuticals, Inc. (Neuraltus Pharma) is a biopharmaceutical company. The company develops and commercializes therapeutics for the treatment of neurodegenerative diseases. Its products under clinical development include NP001, and NP003. Neuraltus Pharma’s NP001 regulates activat...

$ 250.00

Read More

Postherpetic Neuralgia-Pipeline Insights, 2015

01 Apr 2015  |  Published by:  DelveInsight
Summary Postherpetic Neuralgia- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Postherpetic Neuralgia. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-l...

$ 1,250.00

Read More

Postherpetic Neuralgia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

01 Apr 2015  |  Published by:  DelveInsight
SummaryDelveInsight’s, Postherpetic Neuralgia-API Insights, 2015,report provides Postherpetic Neuralgia drugs marketed details and API Manufacturers details across the globe along with the location. The report gives the clear idea on the United States Drug Master File (USDMF) and Europe DMF filed by...

$ 1,250.00

Read More

Neuralgia-Pipeline Insights, 2015

01 Apr 2015  |  Published by:  DelveInsight
Summary Neuralgia- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Neuralgia. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Neura...

$ 1,250.00

Read More

Acute Sensorineural Hearing Loss-Pipeline Insights, 2015

01 Apr 2015  |  Published by:  DelveInsight
Summary Acute Sensorineural Hearing Loss- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Acute Sensorineural Hearing Loss. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in...

$ 1,250.00

Read More

Global Neural Navigation System Industry 2015 Market Research Report

20 Mar 2015  |  Published by:  9Dimen Research
2015 Global Neural Navigation System Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Neural Navigation System industry, focusing on the main regions (North America, Europe and Asia) and the main countries (United States, Germany, ...

$ 2,850.00

Read More

Trigeminal Neuralgia - Pipeline Review, H1 2015

10 Feb 2015  |  Published by:  Global Markets Direct
Summary‘Trigeminal Neuralgia - Pipeline Review, H1 2015’, provides an overview of the Trigeminal Neuralgia’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Trigeminal Neuralgia, complete with comparative analysis at various stages, therapeutics...

$ 2,000.00

Read More

Acute Sensorineural Hearing Loss - Pipeline Review, H1 2015

22 Jan 2015  |  Published by:  Global Markets Direct
Summary‘Acute Sensorineural Hearing Loss - Pipeline Review, H1 2015’, provides an overview of the Acute Sensorineural Hearing Loss’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Acute Sensorineural Hearing Loss, complete with comparative anal...

$ 2,000.00

Read More

Acute Sensorineural Hearing Loss - Pipeline Review, H2 2014

31 Dec 2014  |  Published by:  Global Markets Direct
Summary ‘Acute Sensorineural Hearing Loss - Pipeline Review, H2 2014’, provides an overview of the Acute Sensorineural Hearing Loss’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Acute Sensorineural Hearing Loss, complete with comparative ana...

$ 2,000.00

Read More

Trigeminal Neuralgia - Pipeline Review, H2 2014

31 Dec 2014  |  Published by:  Global Markets Direct
Summary ‘Trigeminal Neuralgia - Pipeline Review, H2 2014’, provides an overview of the Trigeminal Neuralgia’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Trigeminal Neuralgia, complete with comparative analysis at various stages, therapeutic...

$ 2,000.00

Read More

Sredneural'skiy medeplavil'nyi zavod (SUMZ) - Company Capsule

14 Nov 2014  |  Published by:  World Market Intelligence
Synopsis"Sredneural'skiy medeplavil'nyi zavod (SUMZ) - Company Capsule" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts, major products and services, financial ratios, financial analysis, key employees.SummaryThis report...

$ 75.00

Read More
Total 33 records.